Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Linhart

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
American Heart Journal|May 29, 2000
New insights in cardiac structural changes in patients with Fabry's diseaseA Linhart, T Palecek, J Bultas, et al.
Bratislavske Lekarske Listy|July 5, 2013
Prediction of coronary vessel involvement on the basis of atherosclerosis risk factor analysisT Kovarnik, A Kral, H Skalicka, et al.
Vnitrni Lekarstvi|April 9, 2008
[Recommended diagnostic and therapeutic approach in arterial hypertension--2007 version. Recommendations of the Czech Hypertension Society]J Widimský, R Cífková, J Spinar, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|September 17, 2016
Injuries in Adults 65 Years of Age and Older Prescribed Muscle RelaxantsMelissa M Derner, Courtney A Linhart, LeeAnna M Pederson, et al.
Folia Biologica|February 13, 2017
Cystatin C Is Associated with the Extent and Characteristics of Coronary Atherosclerosis in Patients with Preserved Renal FunctionA Král, T Kovárník, Z Vaníčková, et al.
Vnitrni Lekarstvi|November 6, 2012
[Diagnosis and treatment of arterial hypertension. 2012 Guidelines of the Czech Hypertension Society]J Filipovský, J Widimský, J Ceral, et al.
Glycobiology|June 18, 2021
Evidence for nutrient-dependent regulation of the COPII coat by O-GlcNAcylationBrittany J Bisnett, Brett M Condon, Noah A Linhart, et al.
European Journal of Clinical Investigation|December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatmentM Beck, R Ricci, U Widmer, et al.
Folia Biologica|November 30, 2011
Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosisA Král, T Kovárník, L Králík, et al.
Casopis Lekaru Ceskych|April 28, 2006
[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]J Lindner, P Jansa, J Kunstýr, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
American Heart Journal|May 29, 2000
New insights in cardiac structural changes in patients with Fabry's diseaseA Linhart, T Palecek, J Bultas, et al.
Bratislavske Lekarske Listy|July 5, 2013
Prediction of coronary vessel involvement on the basis of atherosclerosis risk factor analysisT Kovarnik, A Kral, H Skalicka, et al.
Vnitrni Lekarstvi|April 9, 2008
[Recommended diagnostic and therapeutic approach in arterial hypertension--2007 version. Recommendations of the Czech Hypertension Society]J Widimský, R Cífková, J Spinar, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|September 17, 2016
Injuries in Adults 65 Years of Age and Older Prescribed Muscle RelaxantsMelissa M Derner, Courtney A Linhart, LeeAnna M Pederson, et al.
Folia Biologica|February 13, 2017
Cystatin C Is Associated with the Extent and Characteristics of Coronary Atherosclerosis in Patients with Preserved Renal FunctionA Král, T Kovárník, Z Vaníčková, et al.
Vnitrni Lekarstvi|November 6, 2012
[Diagnosis and treatment of arterial hypertension. 2012 Guidelines of the Czech Hypertension Society]J Filipovský, J Widimský, J Ceral, et al.
Glycobiology|June 18, 2021
Evidence for nutrient-dependent regulation of the COPII coat by O-GlcNAcylationBrittany J Bisnett, Brett M Condon, Noah A Linhart, et al.
European Journal of Clinical Investigation|December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatmentM Beck, R Ricci, U Widmer, et al.
Folia Biologica|November 30, 2011
Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosisA Král, T Kovárník, L Králík, et al.
Casopis Lekaru Ceskych|April 28, 2006
[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]J Lindner, P Jansa, J Kunstýr, et al.
Pageof 11